Skip to main content
PRVAPrivia Health Group, Inc.Sell6.1·$22.48+1.40%
Open full analysis

Privia Health Group, Inc. (PRVA) Stock Analysis

Recovery setup

SellModerate Confidence

Healthcare · Health Information Services

Sell if holding. Engine safety override at $22.48: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10 and A.R:R 3.0:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Below long-term trend.

Privia Health is a technology-driven physician-enablement company organizing 5,380 providers into Medical Groups across 24 states and DC, integrating fee-for-service and value-based care programs including MSSP ACOs serving 298,000+ Medicare beneficiaries. Revenue flows from FFS... Read more

$22.48+26.6% A.UpsideScore 6.1/10#3 of 12 Health Information Services
QualityF-score7 / 9FCF yield3.96%
Stop $21.31Target $28.44(analyst − 10%)A.R:R 3.0:1
Analyst target$31.60+40.6%20 analysts
$28.44our TP
$22.48price
$31.60mean
$40

Sell if holding. Engine safety override at $22.48: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10 and A.R:R 3.0:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 43. Score 6.1/10, moderate confidence.

Passes 8/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 57d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-10
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202657d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.5 < 4.0)

Key Metrics

P/E (TTM)130.4
P/E (Fwd)20.4
Mkt Cap$2.8B
EV/EBITDA51.0
Profit Mgn1.0%
ROE3.6%
Rev Growth25.8%
Beta0.87
DividendNone
Rating analysts27

Quality Signals

Piotroski F7/9

Options Flow

P/C0.22bullish
IV110%elevated
Max Pain$28+22.3% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographiccertain U.S. states
    10-K Item 1A: 'The operations of the Company and its Medical Groups are concentrated in certain U.S. states, which makes us sensitive to regulatory, economic, public health, environmental, competitive and other conditions'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Operating Margin
0.5
Net Margin
0.5
Roe
1.2
Roa
1.2
Moat
4.9
Current Ratio
5.8
Piotroski F
7.8
Fcf Quality
10.0
Excellent cash conversion: 508% FCF/NINo competitive moatStrong Piotroski F-Score: 7/9
GatesMomentum 5.5>=5.5A.R:R 3.0 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 57d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
43 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $20.48Resistance $23.95

Price Targets

$21
$28
A.Upside+26.5%
A.R:R3.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.5 < 4.0)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-06 (57d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is PRVA stock a buy right now?

Sell if holding. Engine safety override at $22.48: Quality below floor (3.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10 and A.R:R 3.0:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 43. Prior stop was $21.31. Score 6.1/10, moderate confidence.

What is the PRVA stock price target?

Take-profit target: $28.44 (+26.6% upside). Prior stop was $21.31. Stop-loss: $21.31.

What are the risks of investing in PRVA?

Quality below floor (3.5 < 4.0).

Is PRVA overvalued or undervalued?

Privia Health Group, Inc. trades at a P/E of 130.4 (forward 20.4). TrendMatrix value score: 7.0/10. Verdict: Sell.

What do analysts say about PRVA?

27 analysts cover PRVA with a consensus score of 4.2/5. Average price target: $32.

What does Privia Health Group, Inc. do?Privia Health is a technology-driven physician-enablement company organizing 5,380 providers into Medical Groups across...

Privia Health is a technology-driven physician-enablement company organizing 5,380 providers into Medical Groups across 24 states and DC, integrating fee-for-service and value-based care programs including MSSP ACOs serving 298,000+ Medicare beneficiaries. Revenue flows from FFS patient care, PMPM care management fees, capitation, and shared savings; operations are concentrated in certain U.S. states.

Related stocks: WAY (Waystar Holding Corp.) · HQY (HealthEquity, Inc.) · HNGE (Hinge Health, Inc.) · TEM (Tempus AI, Inc.) · OMCL (Omnicell, Inc.)
Home Stocks PRVA

Latest news

Latest News

Benzinga19d ago
Benzinga38d agoAnalyst
Benzinga40d agoEarnings
Benzinga40d ago
Benzinga68d ago